01.09.2015 Views

A Path to Prosperity New Directions for African Livestock

GALVmed Impetus Strategy Paper

GALVmed Impetus Strategy Paper

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Annex 3<br />

Overview of GALVmed<br />

GALVmed is a registered charity that began<br />

operations in November 2005. Since its inception<br />

GALVmed has supported the Millennium<br />

Development Goals by playing a major role in<br />

poverty reduction and livelihood enhancement<br />

through lives<strong>to</strong>ck interventions. The charity’s<br />

mission is <strong>to</strong> protect lives<strong>to</strong>ck and save human<br />

lives by:<br />

> Developing, registering and launching several<br />

vaccines, pharmaceutical and diagnostic<br />

products over the next 10 years<br />

> Partnering with organisations in developing<br />

countries <strong>to</strong> ensure sustainable research,<br />

production and delivery of new products <strong>to</strong> poor<br />

lives<strong>to</strong>ck keepers<br />

> In<strong>for</strong>ming stakeholders on the links between<br />

lives<strong>to</strong>ck and poverty and the role of lives<strong>to</strong>ck<br />

health in achieving the Millennium Development<br />

Goal of eradicating extreme poverty and hunger<br />

> Facilitating dialogue and collaboration in<br />

research ef<strong>for</strong>ts <strong>for</strong> new lives<strong>to</strong>ck vaccines,<br />

medicines and diagnostic systems<br />

GALVmed focuses its ef<strong>for</strong>ts on sub-Saharan <strong>African</strong><br />

and Southern Asian countries afflicted by both<br />

extreme poverty and animal diseases.<br />

GALVmed prides itself on engaging with<br />

stakeholders through core values of integrity,<br />

pro-poor empathy, focus, professionalism,<br />

competency, transparency, commitment and<br />

progressiveness. Since its launch, GALVmed has<br />

grown considerably. The organisation receives<br />

financial backing from the Bill and Melinda Gates<br />

Foundation, the UK’s Department <strong>for</strong> International<br />

Development (DFID) along with specific project<br />

funding from numerous other sources. GALVmed<br />

has partnerships with the pharmaceutical industry,<br />

non-governmental organisations (NGOs),<br />

government organisations and international<br />

agencies and foundations. These partnerships<br />

are vital <strong>to</strong> GALVmed’s existence and the success<br />

of its mission. GALVmed strives <strong>to</strong> ensure that its<br />

decisions are driven by regular dialogue with<br />

community stakeholders.<br />

GALVmed's work is guided by a Board of Direc<strong>to</strong>rs<br />

and observers <strong>to</strong> the board. The board members<br />

reflect a wide range of nationalities and expertise<br />

from the private and public sec<strong>to</strong>rs, along with<br />

research and civil society communities. The current<br />

list of direc<strong>to</strong>rs and observers can be found on<br />

GALVmed's web site 15 . The Board has four<br />

sub-committees: policy and external affairs; finance<br />

/audit; technical; and global access. GALVmed is<br />

further supported by external advisers: an Expert<br />

Scientific Advisory Committee reviews all GALVmed<br />

research plans and a unique Global Access Advisory<br />

Committee, that includes internationally-renowned<br />

experts from several countries on regulation, quality<br />

control, manufacturing, government, distribution,<br />

development, policy, sociology and other related<br />

areas, provides advice <strong>to</strong> GALVmed on all nonscientific<br />

aspects of its work. This includes, <strong>for</strong><br />

example, the development of socio-economic<br />

impact <strong>to</strong>ols <strong>for</strong> the lives<strong>to</strong>ck sec<strong>to</strong>r, strategic<br />

partnerships, production, commercialisation and<br />

sustained delivery of new products, advocacy,<br />

farmer engagement and communications.<br />

GALVmed has a number of qualities that makes it an<br />

effective organisation in terms of impacting the lives<br />

and livelihoods of poor lives<strong>to</strong>ck farmers in Africa<br />

and South Asia.<br />

These strengths include the following:<br />

> GALVmed is relatively new and relatively creative<br />

in its approach. This has helped GALVmed<br />

engage with a number of persistent problems<br />

in the animal health and development world and<br />

<strong>for</strong>mulate solutions.<br />

> Galvmed has a very business-orientated<br />

approach. This reflects GALVmed's private<br />

sec<strong>to</strong>r links and staff experience. GALVmed is<br />

careful about what it invests in. When<br />

investments are made they are closely<br />

moni<strong>to</strong>red against a business plan that includes<br />

miles<strong>to</strong>nes and outputs against agreed<br />

timelines. This allows GALVmed <strong>to</strong> alter course<br />

rapidly <strong>to</strong> invest in success and pull out if results<br />

are not possible. GALVmed is lucky <strong>to</strong> have<br />

donors that understand and support this flexible<br />

and output-orientated approach.<br />

15 http://www.galvmed.org/about-galvmed/leadership<br />

The Impetus Strategy Paper I Page 61

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!